Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: Gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation

Radiology

Volumn 271, Issue 2, 2014, Pages 416-425

  Han, Na Yeon ^a   Park, Beom Jin ^a   Sung, Deuk Jae ^a   Kim, Min Ju ^a   Cho, Sung Bum ^a   Lee, Chang Hee ^b   Jang, Yun Jin ^c   Kim, So Yeon ^d   Kim, Dong Sik ^a   Um, Soon Ho ^a   Won, Nam Hee ^a   Yang, Kyung Sook ^a  

^a College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; GADOXETIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; OXALIPLATIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CASE CONTROL STUDY; CHEMOTHERAPY INDUCED FOCAL HEPATOPATHY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; FEMALE; FOCAL HEPATOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INFORMED CONSENT; INTESTINE CANCER; KAPPA STATISTICS; LESION TO LIVER CONTRAST RATIO; LIVER DISEASE; LIVER METASTASIS; LIVER VENOOCCLUSIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVER VARIATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; SYMPTOMATOLOGY; TUMOR VOLUME; UNIVARIATE ANALYSIS; VERY ELDERLY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG-INDUCED LIVER INJURY; FEMALE; FLUOROURACIL; GADOLINIUM DTPA; GASTROINTESTINAL NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 84899545901     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13131810     Document Type: Article

References (29)

1. Alberts SR, Wagman LD. Chemotherapy for colorectal cancer liver metastases. Oncologist 2008;13(10):1063-1073.
2. Sugihara K, Uetake H. Therapeutic strategies for hepatic metastasis of colorectal cancer: overview. J Hepatobiliary Pancreat Sci 2012;19(5):523-527.
3. Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009;16(2):137-144.
4. Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 2008;34(6):609-614.
5. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11(7):860-868.
6. Robinson PJ. The effects of cancer chemotherapy on liver imaging. Eur Radiol 2009;19(7):1752-1762.
7. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15(3):460-466.
8. Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011;258(1):41-56.
9. Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol 2006;187(1):W43-W52.
10. Larrey D, Fréneaux E, Berson A, et al. Peliosis hepatis induced by 6-thioguanine administration. Gut 1988;29(9):1265-1269.
11. Shanbhogue AK, Virmani V, Vikram R, et al. Spectrum of medication-induced complications in the abdomen: role of cross-sectional imaging. AJR Am J Roentgenol 2011;197(2):W286-W294.
12. Arakawa Y, Shimada M, Utsunomya T, et al. Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res 2013;43(6):685-689.
13. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230(1):266-275.
14. Kim YK, Park G, Kim CS, Yu HC, Han YM. Diagnostic efficacy of gadoxetic acidenhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT. Br J Radiol 2012;85(1013):539-547.
15. Kim YK, Lee MW, Lee WJ, et al. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol 2012;47(3):159-166.
16. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 2010;20(6):1431-1441.
17. Rubbia-Brandt L, Lauwers GY, Wang H, et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin- associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010;56(4):430-439.
18. Lee MH, Kim SH, Kim H, Lee MW, Lee WJ. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging. Korean J Radiol 2011;12(4):439-449.
19. Inan N, Kilinc F, Sarisoy T, Gumustas S, Akansel G, Demirci A. Diffusion weighted MR imaging in the differential diagnosis of haemangiomas and metastases of the liver. Radiol Oncol 2010;44(1):24-29.
20. Ni Y, Chen F, Wang H, Feng Y, Li J, Jiang Y. Proper definitions of MRI contrast enhancement in liver tumors. J Gastroenterol 2010;45(3):349-350; author reply 351-352.
21. Poston GJ, Adam R, Alberts S, et al. Onco-Surge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 2005;23(28):7125-7134.
22. Nam SJ, Cho JY, Lee HS, et al. Chemotherapy-associated hepatopathy in Korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. Korean J Pathol 2012;46(1):22-29.
23. Shin NY, Kim MJ, Lim JS, et al. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 2012;22(4):864-871.
24. Ward J, Guthrie JA, Sheridan MB, et al. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxideenhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 2008;26(26):4304-4310.
25. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24(13):2065-2072.
26. Purysko AS, Remer EM, Veniero JC. Focal liver lesion detection and characterization with GD-EOB-DTPA. Clin Radiol 2011;66(7):673-684.
27. Erturk SM, Ichikawa T, Sano K, Motosugi U, Sou H, Araki T. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value. J Comput Assist Tomogr 2008;32(6):865-871.
28. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226(1):71-78.
29. Zhang Q, Yu NN, Wen LJ, et al. A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage. Eur J Radiol 2012;81(11):2943-2946.